Abstract
analyses the independent prognostic factors according to the histology of the primary tumor are as follows: Breast e KPS < 70% (HR Z 1.84); no PTC (HR Z 1.47), no chemotherapy [CT] (HR Z 1.49); no RS (HR Z 2.34). Lung e KPS < 70% (HR Z 1.80); no PTC (HR Z 2.10); no FT (HR Z 2.90 for RS and 1.72 for SG, respectively). Melanoma e no FT (HR Z 4.38 for RS and 2.28 for SG, respectively). GI e no SG (HR Z 4.19). All tumors e KPS < 70% (HR Z 1.70); no PTC (HR Z 1.42); no CT (HR Z 1.42), no FT (HR Z 2.48 for RS and 2.11 for SG, respectively); ECM (HR Z 1.48). *All p value < 0.05. Conclusions: Comparing our data to DS-GPA we observe differences in prognostic factors for breast cancer (PTC, CT and FT), lung cancer (PTC and FT), melanoma (FT) and GI (FT). ECM was just significant when it was analyzed all tumor types together and the number of BM was not an independent factor in this study. The FT was correlated with improved survival in all tumor histology. The inclusion of new prognostic factors could further refine DS-GPA. Author Disclosure: M.G. Silva: None. D.F.G. Neves: None. F.L.C. Faustino: None. D.F. Ferreira: None. A.C.A. Pellizon: None. R.C. Fogaroli: None. D.G. Castro: None. M.J. Chen: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
